349 related articles for article (PubMed ID: 25001132)
21. Gene polymorphisms of the renin-angiotensin-aldosterone system and angiotensin II type 1-receptor activating antibodies in renal rejection.
Zhang G; Wang H; Wang F; Yu L; Yang X; Meng J; Qin W; Wu G; Li J; Yang A; Zhou Y; Zhang R
Tohoku J Exp Med; 2007 Nov; 213(3):203-14. PubMed ID: 17984617
[TBL] [Abstract][Full Text] [Related]
22. Renin-angiotensin system polymorphisms: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patients.
Akman B; Tarhan C; Arat Z; Sezer S; Ozdemir FN
Ren Fail; 2009; 31(3):196-200. PubMed ID: 19288324
[TBL] [Abstract][Full Text] [Related]
23. Renin-Angiotensin-Aldosterone System Antagonism and Polycystic Kidney Disease Progression.
Hian CK; Lee CL; Thomas W
Nephron; 2016; 134(2):59-63. PubMed ID: 27476173
[TBL] [Abstract][Full Text] [Related]
24. Interpretation of renal volume in autosomal dominant polycystic kidney disease and relevant clinical implications.
Masoumi A; Elhassan E; Schrier RW
Iran J Kidney Dis; 2011 Jan; 5(1):1-8. PubMed ID: 21189426
[TBL] [Abstract][Full Text] [Related]
25. Modifier effect of the Glu298Asp polymorphism of endothelial nitric oxide synthase gene in autosomal-dominant polycystic kidney disease.
Stefanakis N; Ziroyiannis P; Trygonis S; Lamnissou K
Nephron Clin Pract; 2008; 110(2):c101-6. PubMed ID: 18815450
[TBL] [Abstract][Full Text] [Related]
26. [Polymorphism in elderly hypertension].
Katsuya T; Ogihara T
Nihon Rinsho; 2005 Jun; 63(6):926-30. PubMed ID: 15948371
[No Abstract] [Full Text] [Related]
27. Effect of enalapril on blood pressure, renal function, and the renin-angiotensin-aldosterone system in cats with autosomal dominant polycystic kidney disease.
Miller RH; Lehmkuhl LB; Smeak DD; DiBartola SP; Radin J
Am J Vet Res; 1999 Dec; 60(12):1516-25. PubMed ID: 10622161
[TBL] [Abstract][Full Text] [Related]
28. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V
Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482
[TBL] [Abstract][Full Text] [Related]
29. [Polymorphic markers of vasoactive hormones genes and progression of renal diseases].
Kamyshova ES; Nosikov VV; Kutyrina IM
Ter Arkh; 2003; 75(6):79-84. PubMed ID: 12920967
[No Abstract] [Full Text] [Related]
30. ACE gene I/D polymorphism and the presence of renal failure or hypertension in autosomal dominant polycystic kidney disease (ADPKD).
Gumprecht J; Zychma MJ; Karasek D; Grzeszczak W
Nephrol Dial Transplant; 2007 May; 22(5):1483. PubMed ID: 17205958
[No Abstract] [Full Text] [Related]
31. Association between gene polymorphisms of the components of the renin-angiotensin-aldosteron system, graft function, and the prevalence of hypertension, anemia, and erythrocytosis after kidney transplantation.
Kujawa-Szewieczek A; Kolonko A; Kocierz M; Szotowska M; Trusolt W; Karkoszka H; Gumprecht J; Chudek J; Więcek A
Transplant Proc; 2011 Oct; 43(8):2957-63. PubMed ID: 21996200
[TBL] [Abstract][Full Text] [Related]
32. Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease.
Pérez-Oller L; Torra R; Badenas C; Milà M; Darnell A
Am J Kidney Dis; 1999 Aug; 34(2):273-8. PubMed ID: 10430974
[TBL] [Abstract][Full Text] [Related]
33. Hypertension in autosomal dominant polycystic kidney disease.
Chapman AB; Stepniakowski K; Rahbari-Oskoui F
Adv Chronic Kidney Dis; 2010 Mar; 17(2):153-63. PubMed ID: 20219618
[TBL] [Abstract][Full Text] [Related]
34. The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1.
Walker D; Consugar M; Slezak J; Rossetti S; Torres VE; Winearls CG; Harris PC
Am J Kidney Dis; 2003 Jan; 41(1):90-4. PubMed ID: 12500225
[TBL] [Abstract][Full Text] [Related]
35. Genetic variation in the renin-angiotensin-aldosterone system is associated with cardiovascular risk factors and early mortality in established coronary heart disease.
Ellis KL; Palmer BR; Frampton CM; Troughton RW; Doughty RN; Whalley GA; Ellis CJ; Pilbrow AP; Skelton L; Yandle TG; Richards AM; Cameron VA
J Hum Hypertens; 2013 Apr; 27(4):237-44. PubMed ID: 22739771
[TBL] [Abstract][Full Text] [Related]
36. NOS3 tagSNPs does not modify the chronic kidney disease progression in autosomal dominant polycystic kidney disease.
Ramanathan G; Periyasamy S; Lakkakula BV
Nephrology (Carlton); 2014 Sep; 19(9):537-41. PubMed ID: 24824375
[TBL] [Abstract][Full Text] [Related]
37. [Genetic polymorphisms of the renin-angiotensin system].
Higaki J; Katsuya T; Ogihara T
Nihon Rinsho; 2001 May; 59(5):847-52. PubMed ID: 11391981
[TBL] [Abstract][Full Text] [Related]
38. Polymorphisms of three genes (ACE, AGT and CYP11B2) in the renin-angiotensin-aldosterone system are not associated with blood pressure salt sensitivity: A systematic meta-analysis.
Sun J; Zhao M; Miao S; Xi B
Blood Press; 2016; 25(2):117-22. PubMed ID: 26556555
[TBL] [Abstract][Full Text] [Related]
39. The effects of the renin-angiotensin-aldosterone system blockers on serum ischemia-modified albumin levels in autosomal dominant polycystic kidney disease.
Ermurat S; Güllülü M; Sarandöl E
Ir J Med Sci; 2022 Dec; 191(6):2777-2783. PubMed ID: 35067861
[TBL] [Abstract][Full Text] [Related]
40. Molecular genetics of the renin-angiotensin-aldosterone system in human hypertension.
Corvol P; Soubrier F; Jeunemaitre X
Pathol Biol (Paris); 1997 Mar; 45(3):229-39. PubMed ID: 9296068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
